Search results
Kohler Partners with Flamingo Estate to Inspire Designing with the Colors of Nature
The Missourian· 1 day agoKOHLER, Wis., May 8, 2024 /PRNewswire/ -- Kohler Co., global leader in kitchen and bath design,...
MARS UNVEILS MULTI-MILLION DOLLAR SUSTAINABLE DAIRY PLAN, MOO'VING DAIRY FORWARD
The Missourian· 2 days agoNew plan to help cut methane, not corners, as part of net zero by 2050 ambition.
Hades 2 - Beginner guide and tips
Shacknews· 23 hours agoSupergiant's long-awaited sequel is a complex roguelike, so much so that a Hades 2's beginner guide is almost essential - even if you're familiar with...
Kate Therapeutics Unveils Platform and Pipeline Progress at American Society of Gene & Cell Therapy...
FOX21 Colorado Springs· 6 hours agoKate Therapeutics Inc. ("KateTx"), a next-generation gene therapy company, will present detailed preclinical efficacy and safety results on its pipeline and platform at the American Society ...
All Arcana cards and how to unlock them - Hades 2
Shacknews· 15 hours agoOur Hades 2 Arcana cards list lays out all of Melinoe's Arcana perks and how to get them.
Ken Ernst Conjures Up Magic Morro in Dell's Super Comics, at Auction
Bleeding Cool· 4 days agoMagic Morro was a Golden Age Dell hero in the Tarzan mold, created by underappreciated artist Ken...
7 Blue-Chip Stocks to Sell in May Before They Crash & Burn
InvestorPlace· 22 hours agoThe stock market is seeking direction and adjusting to the reality of higher for longer interest...
Rumor That Perfect Dark Is "In A Very Rough State" Corroborated By Multiple Sources - Gameranx
Gameranx· 1 day agoThe Perfect Dark reboot is rumored to be in 'a very rough state', with several sources corroborating...
Mother’s Day dining: 5 great brunch, dinner options in the San Fernando Valley
Los Angeles Daily News· 7 days agoAn online ad just popped up on my email that pretty well defies the conundrum of Mother’s Day for...
Vigil Neuroscience Inc (VIGL) Q1 2024 Earnings: Challenges Persist Amid Clinical Developments
GuruFocus.com via Yahoo Finance· 2 days agoThe company's lead clinical candidate, iluzanebart, targets adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), and is currently progressing through a Phase 2 trial ...